Logo image of OGI

ORGANIGRAM GLOBAL INC (OGI) Stock Fundamental Analysis

USA - NASDAQ:OGI - CA68617J1003 - Common Stock

1.62 USD
+0.03 (+1.89%)
Last: 10/31/2025, 8:06:11 PM
1.63 USD
+0.01 (+0.62%)
After Hours: 10/31/2025, 8:06:11 PM
Fundamental Rating

3

OGI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 192 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of OGI have multiple concerns. While showing a medium growth rate, OGI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year OGI has reported negative net income.
OGI had a positive operating cash flow in the past year.
OGI had negative earnings in each of the past 5 years.
OGI had negative operating cash flow in 4 of the past 5 years.
OGI Yearly Net Income VS EBIT VS OCF VS FCFOGI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

OGI has a better Return On Assets (1.38%) than 83.33% of its industry peers.
OGI has a Return On Equity of 2.02%. This is amongst the best in the industry. OGI outperforms 83.33% of its industry peers.
Industry RankSector Rank
ROA 1.38%
ROE 2.02%
ROIC N/A
ROA(3y)-32.3%
ROA(5y)-30.36%
ROE(3y)-36.4%
ROE(5y)-36.38%
ROIC(3y)N/A
ROIC(5y)N/A
OGI Yearly ROA, ROE, ROICOGI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

OGI has a Profit Margin of 3.47%. This is amongst the best in the industry. OGI outperforms 82.29% of its industry peers.
The Operating Margin and Gross Margin are not available for OGI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 3.47%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OGI Yearly Profit, Operating, Gross MarginsOGI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

OGI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OGI has been increased compared to 1 year ago.
OGI has more shares outstanding than it did 5 years ago.
OGI has a worse debt/assets ratio than last year.
OGI Yearly Shares OutstandingOGI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
OGI Yearly Total Debt VS Total AssetsOGI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of -0.38, we must say that OGI is in the distress zone and has some risk of bankruptcy.
OGI has a Altman-Z score of -0.38. This is comparable to the rest of the industry: OGI outperforms 48.44% of its industry peers.
OGI has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.14, OGI perfoms like the industry average, outperforming 48.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z -0.38
ROIC/WACCN/A
WACC7.91%
OGI Yearly LT Debt VS Equity VS FCFOGI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 2.59 indicates that OGI has no problem at all paying its short term obligations.
OGI has a Current ratio (2.59) which is in line with its industry peers.
OGI has a Quick Ratio of 1.42. This is a normal value and indicates that OGI is financially healthy and should not expect problems in meeting its short term obligations.
OGI has a worse Quick ratio (1.42) than 61.98% of its industry peers.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 1.42
OGI Yearly Current Assets VS Current LiabilitesOGI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 98.88% over the past year.
The Revenue has grown by 38.86% in the past year. This is a very strong growth!
The Revenue has been growing by 14.73% on average over the past years. This is quite good.
EPS 1Y (TTM)98.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
Revenue 1Y (TTM)38.86%
Revenue growth 3Y26.37%
Revenue growth 5Y14.73%
Sales Q2Q%72.41%

3.2 Future

Based on estimates for the next years, OGI will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.93% on average per year.
Based on estimates for the next years, OGI will show a quite strong growth in Revenue. The Revenue will grow by 18.15% on average per year.
EPS Next Y119.5%
EPS Next 2Y41.59%
EPS Next 3Y28.91%
EPS Next 5Y19.93%
Revenue Next Year57.11%
Revenue Next 2Y34.49%
Revenue Next 3Y26.71%
Revenue Next 5Y18.15%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OGI Yearly Revenue VS EstimatesOGI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M
OGI Yearly EPS VS EstimatesOGI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

OGI is valuated quite expensively with a Price/Forward Earnings ratio of 1124.95.
Based on the Price/Forward Earnings ratio, OGI is valued a bit cheaper than 67.71% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of OGI to the average of the S&P500 Index (22.55), we can say OGI is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 1124.95
OGI Price Earnings VS Forward Price EarningsOGI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OGI Per share dataOGI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
OGI's earnings are expected to grow with 28.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.59%
EPS Next 3Y28.91%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OGI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORGANIGRAM GLOBAL INC

NASDAQ:OGI (10/31/2025, 8:06:11 PM)

After market: 1.63 +0.01 (+0.62%)

1.62

+0.03 (+1.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)12-16 2025-12-16/amc
Inst Owners6.05%
Inst Owner Change-0.8%
Ins Owners2.53%
Ins Owner ChangeN/A
Market Cap217.61M
Revenue(TTM)223.82M
Net Income(TTM)7.77M
Analysts77.5
Price Target2.21 (36.42%)
Short Float %5.73%
Short Ratio6.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)376.4%
Min EPS beat(2)-164.03%
Max EPS beat(2)916.83%
EPS beat(4)1
Avg EPS beat(4)56.27%
Min EPS beat(4)-400%
Max EPS beat(4)916.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.51%
Min Revenue beat(2)3.01%
Max Revenue beat(2)6%
Revenue beat(4)3
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-12.23%
Max Revenue beat(4)6%
Revenue beat(8)5
Avg Revenue beat(8)1.52%
Revenue beat(12)6
Avg Revenue beat(12)-1.43%
Revenue beat(16)9
Avg Revenue beat(16)0.17%
PT rev (1m)-0.34%
PT rev (3m)6.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25%
EPS NY rev (1m)0%
EPS NY rev (3m)138.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1124.95
P/S 1.36
P/FCF N/A
P/OCF 110.84
P/B 0.79
P/tB 1.08
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)0
Fwd EY0.09%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.01
OCFY0.9%
SpS1.19
BVpS2.05
TBVpS1.5
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.38%
ROE 2.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.47%
GM N/A
FCFM N/A
ROA(3y)-32.3%
ROA(5y)-30.36%
ROE(3y)-36.4%
ROE(5y)-36.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 122.48%
Cap/Sales 8.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 1.42
Altman-Z -0.38
F-Score3
WACC7.91%
ROIC/WACCN/A
Cap/Depr(3y)118.74%
Cap/Depr(5y)166.77%
Cap/Sales(3y)18.54%
Cap/Sales(5y)32.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
EPS Next Y119.5%
EPS Next 2Y41.59%
EPS Next 3Y28.91%
EPS Next 5Y19.93%
Revenue 1Y (TTM)38.86%
Revenue growth 3Y26.37%
Revenue growth 5Y14.73%
Sales Q2Q%72.41%
Revenue Next Year57.11%
Revenue Next 2Y34.49%
Revenue Next 3Y26.71%
Revenue Next 5Y18.15%
EBIT growth 1Y-79.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year148.17%
EBIT Next 3Y46.25%
EBIT Next 5Y30.62%
FCF growth 1Y78.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y106.64%
OCF growth 3YN/A
OCF growth 5YN/A

ORGANIGRAM GLOBAL INC / OGI FAQ

Can you provide the ChartMill fundamental rating for ORGANIGRAM GLOBAL INC?

ChartMill assigns a fundamental rating of 3 / 10 to OGI.


What is the valuation status of ORGANIGRAM GLOBAL INC (OGI) stock?

ChartMill assigns a valuation rating of 1 / 10 to ORGANIGRAM GLOBAL INC (OGI). This can be considered as Overvalued.


What is the profitability of OGI stock?

ORGANIGRAM GLOBAL INC (OGI) has a profitability rating of 3 / 10.


What is the earnings growth outlook for ORGANIGRAM GLOBAL INC?

The Earnings per Share (EPS) of ORGANIGRAM GLOBAL INC (OGI) is expected to grow by 119.5% in the next year.